Ireland
--:--IST
Latest
Clinical Trials in France / NCT06190080
Starting soon Not applicable

Outcome of Children With Eosinophilic Esophagitis

NCT06190080 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2024-03
Last updated
2024-01-16

Condition(s) studied

Esophagitis, Eosinophilic

Investigational drug(s) / intervention(s)

Digestive endoscopy

Digestive endoscopy: Digestive endoscopies are performed in the operative room under general anaesthetic 3 months after the introduction or change of treatment. Biopsies of the upper, middle and lower thirds of the esophagus will be taken and analyzed for pathology.

Study summary

The investigator would like to create a prospective cohort of patients in order to describe eosinophilic esophagitis with the specificities corresponding to our geographical territory, and to study their evolution at 3 months, 6 months, 12 months, 18 months and 24 months.

This study would also enable us to investigate the quality of life of these chronically ill patients

Eligibility

Sex
ALL
Min age
2 Years
Max age
17 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of OE according to the diagnostic criteria of the PNDS published in July 2022 * Due to start treatment. * informed consent from one of the 2 parents or the representative of parental authority. * Membership of a social security scheme. Exclusion Criteria: \-

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hôpitaux pédiatriques de Nice CHU Lenval Nice France

More Fondation Lenval trials in France

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06190080 on ClinicalTrials.gov ↗ ← All trials in France